Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: Alzheimer's disease (AD) is increasingly recognized as a multifactorial network disorder in which amyloid and tau pathology interact with mitochondrial dysfunction, neuroinflammation, metabolic impairment, vascular dysregulation, and synaptic failure. This review provides an integrative, systems-level synthesis of these mechanisms with emphasis on diagnostic and therapeutic implication...
Alzheimer's disease (AD) is characterized by progressive brain network disintegration, yet quantifying this process at an individual level remains challenging. This study explores the potential of an individualized differential structural covariance network (IDSCN) as a graph theory-based biomarker to capture disease-specific network reorganization. We found that throughout the AD spectrum, signif...
OBJECTIVES: Amyloid-β (Aβ) PET is crucial for diagnosing and monitoring Alzheimer's disease (AD), but its high cost and radiation exposure limit its u...
This study presents Latent Diffusion Autoencoder (LDAE), a novel encoder-decoder diffusion-based framework for efficient and meaningful unsupervised l...
OBJECTIVES: Amyloid-lowering immunotherapies can cause amyloid-related imaging abnormalities (ARIA), requiring brain MRI for detection and monitoring....
Alzheimer's disease (AD) -the most common form of dementia- begins with mild memory loss and gradually progresses, eventually resulting in a generaliz...
Deep learning algorithms optimize data by enhancing resolution and suppressing noise associated with biological knowledge. The root issue is that, for...
PURPOSE OF REVIEW: Hypertension remains a leading modifiable risk factor for cardiovascular and renal conditions and dementia. Given its rising global...
Early identification of mild cognitive impairment (MCI) progressing to Alzheimer's disease (AD) is of paramount importance. Despite the notable advanc...
BACKGROUND: Mild cognitive impairment (MCI), a precursor to Alzheimer's disease (AD), requires precise early diagnosis. Single-omics approaches often ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and impaired daily functio...
BACKGROUND: Late-life depression (LLD) features recurrent episodes and frequently co-exists with cognitive impairment, which predicts worse outcomes a...
Human cognition and behavior rely on the integration of large-scale neural networks that connect the cerebral cortex and subcortical structures. Emerg...
BACKGROUND: Postoperative delirium is associated with increased morbidity, mortality, future cognitive decline, or dementia. Understanding the neural ...
Artificial intelligence (AI) already influences how older adults are identified for services, supported between provider visits, and referred for care...
This article introduces prosocial artificial intelligence (AI) as a transformative framework for addressing oral health disparities among people with ...
BACKGROUND: Cognitive impairment in older adults poses a growing public health challenge, yet accessible screening tools remain limited. We aimed to d...
Label-free molecular imaging that enables the construction of a molecular atlas of biological tissues is vital for understanding complex physiological...
With the increasing Alzheimer's disease (AD) prevalence, morbidity, and mortality, its early diagnosis is particularly important. The multi-modal data...
Patients tend to lose the ability to smile during the course of dementia. However, such impairments have rarely been reported, likely due to challenge...